Back to search
FDAFDA · Food and drugs·Recall number D-0353-2023

Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured by Lloyd Inc., Shenandoah, IA, 51601, Distributed by: Alvogen Inc, Pine Brook, NJ 07058, NDC 47781-654-90.

Published March 8, 2023 · Recall initiated: February 6, 2023

Summary

FDA records drug Class II recall D-0353-2023, published March 8, 2023 and initiated February 6, 2023. Recalling firm: Alvogen, Inc; Status: Terminated; Reported quantity: 21,276 bottles; Lot: Lot # HE02221, Exp. 05/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Sub-Potent Drug: Out of specification for assay at the 24 month interval.

What to do

Voluntary: Firm initiated · Letter

Get an email if LEVOTHYROXINE SODIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LEVOTHYROXINE SODIUM
Manufacturer
Alvogen, Inc
Distributor
Nationwide and Puerto Rico.
UPC
0347781649906
Lot
Lot # HE02221, Exp. 05/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured by Lloyd Inc., Shenandoah, IA, 51601, Distributed by: Alvogen Inc, Pine Brook, NJ 07058, NDC 47781-654-90. recalled?

Yes. FDA published recall D-0353-2023 on March 8, 2023. Reported hazard: Sub-Potent Drug: Out of specification for assay at the 24 month interval.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LEVOTHYROXINE SODIUM. UPC: 0347781649906.